| human | Q5 |
| P496 | ORCID iD | 0000-0002-9375-0489 |
| P1153 | Scopus author ID | 56862352200 |
| P106 | occupation | researcher | Q1650915 |
| P5008 | on focus list of Wikimedia project | WikiProject COVID-19 | Q87748614 |
| Q90708283 | "No more falling through the cracks": A qualitative study to inform measurement of integration of care of HIV and opioid use disorder |
| Q59334585 | 1470. Neurocognitively-Acting Potentially Inappropriate Medications, Alcohol, and Community-Acquired Pneumonia Among Patients with and Without HIV |
| Q50330676 | A Cross-Sectional Online Survey of HIV Pre-Exposure Prophylaxis Adoption Among Primary Care Physicians |
| Q90292815 | A Cross-sectional Survey of Internal Medicine Resident Knowledge, Attitudes, Behaviors, and Experiences Regarding Pre-Exposure Prophylaxis for HIV Infection |
| Q35839871 | A complex splicing defect associated with homozygous ankyrin-deficient hereditary spherocytosis |
| Q64111299 | A conceptual model for understanding post-release opioid-related overdose risk |
| Q37196954 | A qualitative study to inform the development of a video game for adolescent HIV prevention |
| Q34181559 | Acetaminophen receipt among HIV-infected patients with advanced hepatic fibrosis |
| Q102220777 | Addressing Unhealthy Alcohol Use and the HIV Pre-exposure Prophylaxis Care Continuum in Primary Care: A Scoping Review |
| Q47695806 | Addressing unhealthy alcohol use among people living with HIV: recent advances and research directions |
| Q59573636 | Alcohol Use |
| Q96953356 | Alcohol Use and Antiretroviral Adherence Among Patients Living with HIV: Is Change in Alcohol Use Associated with Change in Adherence? |
| Q47588185 | Alcohol and Mortality: Combining Self-Reported (AUDIT-C) and Biomarker Detected (PEth) Alcohol Measures Among HIV Infected and Uninfected |
| Q92831851 | Alcohol and drug use, partner PrEP use and STI prevalence among people with HIV |
| Q100431599 | All-cause mortality among males living with and without HIV initiating long-term opioid therapy, and its association with opioid dose, opioid interruption and other factors |
| Q46428104 | Ankyrin-linked hereditary spherocytosis in an African-American kindred |
| Q94953644 | Are we missing opioid-related deaths among people with HIV? |
| Q90260329 | Association of Alcohol Screening Scores With Adverse Mental Health Conditions and Substance Use Among US Adults |
| Q40049988 | Association of Cannabis, Stimulant, and Alcohol use with Mortality Prognosis Among HIV-Infected Men. |
| Q90918967 | Association of Prescribed Opioids With Increased Risk of Community-Acquired Pneumonia Among Patients With and Without HIV |
| Q94550818 | Barriers and Facilitators to Clinician Readiness to Provide Emergency Department-Initiated Buprenorphine |
| Q99255065 | Barriers and Facilitators to Providing HIV Preexposure Prophylaxis among Buprenorphine Prescribers: A Pilot Qualitative Study |
| Q88715233 | Brief Report: The Association of Chronic Pain and Long-Term Opioid Therapy With HIV Treatment Outcomes |
| Q53647157 | Can Primary Care Practices Help Address the Health Crisis Fueled by Prescription Opioids? |
| Q130264941 | Cannabis use disorder and adverse cardiovascular outcomes: A population‐based retrospective cohort analysis of adults from Alberta, Canada |
| Q88957971 | Changes in alcohol use associated with changes in HIV disease severity over time: A national longitudinal study in the Veterans Aging Cohort |
| Q36466068 | Combining rapid HIV testing and a brief alcohol intervention in young unhealthy drinkers in the emergency department: a pilot study |
| Q92122194 | Common and Challenging Behaviors Among Individuals on Long-term Opioid Therapy |
| Q38667017 | Complementary and Alternative Medicine Among Persons living with HIV in the Era of Combined Antiretroviral Treatment |
| Q104793945 | Conceptualizing the effects of the COVID-19 pandemic on people with opioid use disorder: an application of the social ecological model |
| Q94604228 | Confronting Another Pandemic: Lessons from HIV can Inform Our COVID-19 Response |
| Q91499465 | Consensus-Based Treatment Approaches for Managing Concerning Behaviors in Patients on Long-term Opioid Therapy for Chronic Pain: Case-Based Applications |
| Q92106969 | Contribution of Behavioral Health Factors to Non-AIDS-Related Comorbidities: an Updated Review |
| Q51764677 | Correction to: Association of Cannabis, Stimulant, and Alcohol use with Mortality Prognosis Among HIV-Infected Men. |
| Q52663409 | Correction to: Complementary and Alternative Medicine Among Persons living with HIV in the Era of Combined Antiretroviral Treatment. |
| Q89146128 | Correction to: Managing Concerning Behaviors in Patients Prescribed Opioids for Chronic Pain: a Delphi Study |
| Q47825385 | Corrigendum to "The Starting Treatment for Ethanol in Primary care Trials (STEP Trials): Protocol for three parallel multi-site stepped care effectiveness studies for unhealthy alcohol use in HIV-positive patients" [Contemp. Clin. Trials 52 (2017) 8 |
| Q92496333 | Disagreement and Uncertainty Among Experts About how to Respond to Marijuana Use in Patients on Long-term Opioids for Chronic Pain: Results of a Delphi Study |
| Q58812576 | Do prescribed opioids impact CD4 count restoration among HIV+ patients initiating antiretroviral therapy? |
| Q100497619 | Does Reducing Drinking in Patients with Unhealthy Alcohol Use Improve Pain Interference, Use of Other Substances, and Psychiatric Symptoms? |
| Q35088330 | Drinking trajectories among HIV-infected men who have sex with men: a cohort study of United States veterans |
| Q90410415 | Drive Times to Opioid Treatment Programs in Urban and Rural Counties in 5 US States |
| Q91272641 | Duration of opioid prescriptions predicts incident nonmedical use of prescription opioids among U.S. veterans receiving medical care |
| Q40715043 | Educating the Primary Care Clinician on Preexposure Prophylaxis for Human Immunodeficiency Virus: A Teachable Moment |
| Q40621786 | Effects of Heavy Drinking on T-Cell Phenotypes Consistent with Immunosenescence in Untreated HIV Infection |
| Q90730513 | Efficacy of Extended-Release Naltrexone on HIV-Related and Drinking Outcomes Among HIV-Positive Patients: A Randomized-Controlled Trial |
| Q30542168 | Electronic media-based health interventions promoting behavior change in youth: a systematic review |
| Q104286951 | Emergency department patients with untreated opioid use disorder: A comparison of those seeking versus not seeking referral to substance use treatment |
| Q44343252 | Erratum to: Trends in Any and High-Dose Opioid Analgesic Receipt Among Aging Patients With and Without HIV. |
| Q89677661 | Frequency and duration of incarceration and mortality among US Veterans with and without HIV |
| Q90035636 | Gender and alcohol use: influences on HIV care continuum in a national cohort of patients with HIV |
| Q34621800 | Guideline-concordant management of opioid therapy among human immunodeficiency virus (HIV)-infected and uninfected veterans |
| Q93023504 | HIV Disease Severity Is Sensitive to Temporal Changes in Alcohol Use: A National Study of VA Patients With HIV |
| Q38716329 | HIV Stigma and Substance Use Among HIV-Positive Russians with Risky Drinking. |
| Q60944705 | HIV pre-exposure prophylaxis for people who inject drugs: Willingness to prescribe among general internists |
| Q42257840 | HIV testing and sexual risk reduction counseling in office-based buprenorphine/naloxone treatment |
| Q38901411 | Hepatic Safety of Buprenorphine in HIV-Infected and Uninfected Patients With Opioid Use Disorder: The Role of HCV-Infection |
| Q35634735 | Heroin Use and HIV Disease Progression: Results from a Pilot Study of a Russian Cohort |
| Q92400199 | High-dose prescribed opioids are associated with increased risk of heroin use among United States military veterans |
| Q36249927 | Human immunodeficiency virus testing practices among buprenorphine-prescribing physicians |
| Q91881271 | Identification and Management of Opioid Use Disorder in Primary Care: an Update |
| Q99708417 | Impact of behavioral and medication treatment for alcohol use disorder on changes in HIV-related outcomes among patients with HIV: A longitudinal analysis |
| Q30894245 | Impact of defined clinical population and missing data on temporal trends in HIV viral load estimation within a health care system |
| Q33637866 | Impact of illicit opioid use on T cell subsets among HIV-infected adults |
| Q64063833 | Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH) |
| Q36457683 | Implementation of integrated stepped care for unhealthy alcohol use in HIV clinics. |
| Q26770054 | In the Clinic. Alcohol Use |
| Q39399374 | Incarceration History and Uncontrolled Blood Pressure in a Multi-Site Cohort |
| Q35418299 | Incarceration and health outcomes in HIV-infected patients: the impact of substance use, primary care engagement, and antiretroviral adherence |
| Q96591738 | Inpatient adoption of medications for alcohol use disorder: A mixed-methods formative evaluation involving key stakeholders |
| Q98285987 | Insights Provided by Depression Screening Regarding Pain, Anxiety, and Substance use in a Veteran Population |
| Q36930788 | Instruments to assess patient-reported safety, efficacy, or misuse of current opioid therapy for chronic pain: a systematic review |
| Q92169547 | Integrated stepped alcohol treatment for patients with HIV and alcohol use disorder: a randomised controlled trial |
| Q98163754 | Integrated stepped alcohol treatment for patients with HIV and at-risk alcohol use: a randomized trial |
| Q90195508 | Integrated stepped alcohol treatment for patients with HIV and liver disease: A randomized trial |
| Q92436591 | Integration of care for HIV and opioid use disorder |
| Q104280959 | Interpersonal factors contributing to tension in the Chinese doctor-patient-family relationship: a qualitative study in Hunan Province |
| Q89563715 | Level of Alcohol Use Associated with HIV Care Continuum Targets in a National U.S. Sample of Persons Living with HIV Receiving Healthcare |
| Q40206466 | Long-term alcohol use patterns and HIV disease severity |
| Q36883731 | Management of problematic behaviours among individuals on long-term opioid therapy: protocol for a Delphi study. |
| Q46249078 | Managing Concerning Behaviors in Patients Prescribed Opioids for Chronic Pain: A Delphi Study |
| Q97546537 | Methadone for Opioid Use Disorder-Decades of Effectiveness but Still Miles Away in the US |
| Q39257931 | Minority Men Who Have Sex with Men Demonstrate Increased Risk for HIV Transmission |
| Q36821137 | Moving HIV pre-exposure prophylaxis into clinical settings: lessons from buprenorphine |
| Q47646675 | Non antiretroviral polypharmacy and adverse health outcomes among HIV-infected and uninfected individuals |
| Q39462762 | Non-medical use of prescription opioids is associated with heroin initiation among US veterans: a prospective cohort study |
| Q36658106 | Number of Drinks to "Feel a Buzz" by HIV Status and Viral Load in Men |
| Q57178651 | Office-Based Addiction Treatment in Primary Care: Approaches That Work |
| Q92845667 | Opioid overdose prevention education for medical students: Adopting harm reduction into mandatory clerkship curricula |
| Q44337554 | Opioid substitution therapy is associated with decreased HIV transmission among people who inject drugs |
| Q87174817 | Opportunities for improving partner notification for HIV: results from a community-based participatory research study |
| Q90666836 | Past year and prior incarceration and HIV transmission risk among HIV-positive men who have sex with men in the US |
| Q35055102 | Patient and provider-reported symptoms in the post-cART era. |
| Q36142875 | Patient-reported symptoms on the antiretroviral regimen efavirenz/emtricitabine/tenofovir |
| Q91978244 | Patterns and Correlates of Prescription Opioid Receipt Among US Veterans: A National, 18-Year Observational Cohort Study |
| Q58588751 | Patterns of Alcohol Use Among Patients Living With HIV in Urban, Large Rural, and Small Rural Areas |
| Q38856715 | Pharmacologic and non-pharmacologic treatments for chronic pain in individuals with HIV: a systematic review |
| Q98936516 | Polypharmacy and frailty among persons with HIV |
| Q91952346 | Polypharmacy in HIV: recent insights and future directions |
| Q112286175 | Polypharmacy-associated risk of hospitalisation among people ageing with and without HIV: an observational study |
| Q98657492 | Practice facilitation to implement alcohol-related care in Veterans Health Administration liver clinics: a study protocol |
| Q92129127 | Predictors of initiation of and retention on medications for alcohol use disorder among people living with and without HIV |
| Q92413244 | Predictors of timely opioid agonist treatment initiation among veterans with and without HIV |
| Q92343676 | Preferences for implementation of HIV pre-exposure prophylaxis (PrEP): Results from a survey of primary care providers |
| Q91143119 | Prevalence and Correlates of Unhealthy Alcohol and Drug Use Among Men Who Have Sex with Men Prescribed HIV Pre-exposure Prophylaxis in Real-World Clinical Settings |
| Q40431814 | Primary Care Physicians' Willingness to Prescribe HIV Pre-exposure Prophylaxis for People who Inject Drugs |
| Q57156774 | Proceedings of the 13th annual conference of INEBRIA |
| Q47108005 | Proceedings of the 14th annual conference of INEBRIA: New York, NY, USA, September 14–15, 2017. |
| Q55553874 | Project ART-ED: alcohol reduction and HIV testing in the emergency department. |
| Q91024575 | Racial disparities in discontinuation of long-term opioid therapy following illicit drug use among black and white patients |
| Q47650978 | Racial/ethnic differences in the association between alcohol use and mortality among men living with HIV. |
| Q54213589 | Receipt of alcohol-related care among patients with HCV and unhealthy alcohol use. |
| Q36514613 | Receipt of opioid analgesics by HIV-infected and uninfected patients |
| Q45326558 | Reply to Osborne & Serdarevic (2017): Potential impact of exposure definition when examining non-medical use of prescription opioids among US veterans. |
| Q45326931 | Reply to Ruan et al. (2017): Non-medical use of prescription opioids is associated with heroin initiation among US veterans |
| Q40833745 | Risk factors associated with acute exacerbation of chronic obstructive pulmonary disease in HIV-infected and uninfected patients. |
| Q36689488 | Risk of mortality and physiologic injury evident with lower alcohol exposure among HIV infected compared with uninfected men. |
| Q36962380 | Sex disparities in overall burden of disease among HIV-infected individuals in the Veterans Affairs healthcare system |
| Q34331354 | Sexual partner notification of HIV infection among a National United States-based sample of HIV-infected men |
| Q37177332 | Stigma, substance use and sexual risk behaviors among HIV-infected men who have sex with men: A qualitative study |
| Q52316330 | Substance use and the HIV care continuum: important advances. |
| Q34247817 | Substance use in older HIV-infected patients |
| Q98775134 | Substance use service availability in HIV treatment programs: Data from the global IeDEA consortium, 2014-2015 and 2017 |
| Q98947703 | The Association Between Prescribed Opioid Receipt and Community-Acquired Pneumonia in Adults: a Systematic Review and Meta-analysis |
| Q36808952 | The Association Between Receipt of Guideline-Concordant Long-Term Opioid Therapy and All-Cause Mortality |
| Q40483691 | The Effect of Substance Use Disorders on the Association Between Guideline-concordant Long-term Opioid Therapy and All-cause Mortality. |
| Q33655576 | The GPA-dependent, spherostomatocytosis mutant AE1 E758K induces GPA-independent, endogenous cation transport in amphibian oocytes |
| Q38791854 | The Starting Treatment for Ethanol in Primary care Trials (STEP Trials): Protocol for Three Parallel Multi-Site Stepped Care Effectiveness Studies for Unhealthy Alcohol Use in HIV-Positive Patients |
| Q98504485 | The United States National Cancer Institute's Coordinated Research Effort on Tobacco Use as a Major Cause of Morbidity and Mortality among People with HIV |
| Q37440320 | The epidemiology of substance use disorders in US Veterans: A systematic review and analysis of assessment methods |
| Q91727737 | The impact of access to addiction specialist on attitudes, beliefs and hospital-based opioid use disorder related care: A survey of hospitalist physicians |
| Q33644060 | The impact of buprenorphine/naloxone treatment on HIV risk behaviors among HIV-infected, opioid-dependent patients |
| Q39760836 | The impact of prescribed opioids on CD4 cell count recovery among HIV-infected patients newly initiating antiretroviral therapy |
| Q37025385 | The next therapeutic challenge in HIV: polypharmacy |
| Q37646713 | The use of message framing to promote sexual risk reduction in young adolescents: a pilot exploratory study |
| Q36693000 | Time, dual roles, and departments of public health: lessons learned in CBPR by an AIDS service organization |
| Q91726632 | Trajectories of Self-Reported Opioid Use Among Patients With HIV Engaged in Care: Results From a National Cohort Study |
| Q37222229 | Trends in Any and High-Dose Opioid Analgesic Receipt Among Aging Patients With and Without HIV |
| Q93030523 | Unhealthy Alcohol Use in Primary Care-The Elephant in the Examination Room |
| Q98385776 | Use of Amphetamine-Type Stimulants Among Emergency Department Patients With Untreated Opioid Use Disorder |
| Q99723426 | Working with HIV clinics to adopt addiction treatment using implementation facilitation (WHAT-IF?): Rationale and design for a hybrid type 3 effectiveness-implementation study |
Search more.